N-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide
C130H115F14N15O7 — CID 158619718
Data last refreshed: (MolForge compound catalog, from PubChem)
IUPACN-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide
SMILESC=C1Cc2ccc(-c3cccnc3[C@H](Cc3cc(F)cc(F)c3)NC(=O)Cn3nc(C(F)F)c4c3C(F)(F)C3CC43)cc2C1.CC(=O)c1cccc(-c2cccnc2[C@H](Cc2cc(C)cc(F)c2)NC(=O)Cc2c[nH]c3ccc(F)cc23)c1.Cc1cc(F)cc(C[C@H](NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)c2ncccc2-c2cccc(C(=O)NCCN(C)C)c2)c1.O=C(Cc1c[nH]c2ccc(O)cc12)C[C@@H](Cc1cc(F)cc(F)c1)c1ncccc1-c1ccccc1
InChIInChI=1S/C35H38F4N6O2.C33H26F6N4O.C32H27F2N3O2.C30H24F2N2O2/c1-22-16-23(18-26(36)17-22)19-29(42-31(46)21-45-30-12-5-4-10-28(30)33(43-45)35(37,38)39)32-27(11-7-13-40-32)24-8-6-9-25(20-24)34(47)41-14-15-44(2)3;1-16-7-18-4-5-19(12-20(18)8-16)23-3-2-6-40-29(23)26(11-17-9-21(34)13-22(35)10-17)41-27(44)15-43-31-28(30(42-43)32(36)37)24-14-25(24)33(31,38)39;1-19-11-21(13-26(34)12-19)14-30(37-31(39)16-24-18-36-29-9-8-25(33)17-28(24)29)32-27(7-4-10-35-32)23-6-3-5-22(15-23)20(2)38;31-23-12-19(13-24(32)16-23)11-21(30-27(7-4-10-33-30)20-5-2-1-3-6-20)14-26(36)15-22-18-34-29-9-8-25(35)17-28(22)29/h6-9,11,13,16-18,20,29H,4-5,10,12,14-15,19,21H2,1-3H3,(H,41,47)(H,42,46);2-6,9-10,12-13,24-26,32H,1,7-8,11,14-15H2,(H,41,44);3-13,15,17-18,30,36H,14,16H2,1-2H3,(H,37,39);1-10,12-13,16-18,21,34-35H,11,14-15H2/t29-;24?,25?,26-;30-;21-/m0001/s1
InChIKeyHXVOXVWEWXGNBY-NUXXFYQHSA-N
MW2265.42 g/mol
LogP26.21
Rot. Bonds35
About N-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide
N-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide (PubChem CID 158619718) has the molecular formula C130H115F14N15O7 and a molecular weight of 2265.42 g/mol. Its IUPAC name is N-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide.
Molecular Properties
| Compound Name | N-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide |
|---|---|
| PubChem CID | 158619718 |
| Molecular Formula | C130H115F14N15O7 |
| Molecular Weight | 2265.42 g/mol |
| Exact Mass | 2263.89 |
| IUPAC Name | N-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide |
| SMILES | C=C1Cc2ccc(-c3cccnc3[C@H](Cc3cc(F)cc(F)c3)NC(=O)Cn3nc(C(F)F)c4c3C(F)(F)C3CC43)cc2C1.CC(=O)c1cccc(-c2cccnc2[C@H](Cc2cc(C)cc(F)c2)NC(=O)Cc2c[nH]c3ccc(F)cc23)c1.Cc1cc(F)cc(C[C@H](NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)c2ncccc2-c2cccc(C(=O)NCCN(C)C)c2)c1.O=C(Cc1c[nH]c2ccc(O)cc12)C[C@@H](Cc1cc(F)cc(F)c1)c1ncccc1-c1ccccc1 |
| InChI | InChI=1S/C35H38F4N6O2.C33H26F6N4O.C32H27F2N3O2.C30H24F2N2O2/c1-22-16-23(18-26(36)17-22)19-29(42-31(46)21-45-30-12-5-4-10-28(30)33(43-45)35(37,38)39)32-27(11-7-13-40-32)24-8-6-9-25(20-24)34(47)41-14-15-44(2)3;1-16-7-18-4-5-19(12-20(18)8-16)23-3-2-6-40-29(23)26(11-17-9-21(34)13-22(35)10-17)41-27(44)15-43-31-28(30(42-43)32(36)37)24-14-25(24)33(31,38)39;1-19-11-21(13-26(34)12-19)14-30(37-31(39)16-24-18-36-29-9-8-25(33)17-28(24)29)32-27(7-4-10-35-32)23-6-3-5-22(15-23)20(2)38;31-23-12-19(13-24(32)16-23)11-21(30-27(7-4-10-33-30)20-5-2-1-3-6-20)14-26(36)15-22-18-34-29-9-8-25(35)17-28(22)29/h6-9,11,13,16-18,20,29H,4-5,10,12,14-15,19,21H2,1-3H3,(H,41,47)(H,42,46);2-6,9-10,12-13,24-26,32H,1,7-8,11,14-15H2,(H,41,44);3-13,15,17-18,30,36H,14,16H2,1-2H3,(H,37,39);1-10,12-13,16-18,21,34-35H,11,14-15H2/t29-;24?,25?,26-;30-;21-/m0001/s1 |
| InChIKey | HXVOXVWEWXGNBY-NUXXFYQHSA-N |
| XLogP | 26.21 |
| TPSA | 292.79 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 166 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2265.42 |
| LogP ≤ 5 | 26.21 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
What is the IUPAC name of N-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide?
The IUPAC name of N-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide (CID 158619718) is N-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide.
What is the SMILES notation for N-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide?
The canonical SMILES for N-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide is C=C1Cc2ccc(-c3cccnc3[C@H](Cc3cc(F)cc(F)c3)NC(=O)Cn3nc(C(F)F)c4c3C(F)(F)C3CC43)cc2C1.CC(=O)c1cccc(-c2cccnc2[C@H](Cc2cc(C)cc(F)c2)NC(=O)Cc2c[nH]c3ccc(F)cc23)c1.Cc1cc(F)cc(C[C@H](NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)c2ncccc2-c2cccc(C(=O)NCCN(C)C)c2)c1.O=C(Cc1c[nH]c2ccc(O)cc12)C[C@@H](Cc1cc(F)cc(F)c1)c1ncccc1-c1ccccc1.
What is the InChIKey of N-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide?
The InChIKey is HXVOXVWEWXGNBY-NUXXFYQHSA-N. The full InChI is InChI=1S/C35H38F4N6O2.C33H26F6N4O.C32H27F2N3O2.C30H24F2N2O2/c1-22-16-23(18-26(36)17-22)19-29(42-31(46)21-45-30-12-5-4-10-28(30)33(43-45)35(37,38)39)32-27(11-7-13-40-32)24-8-6-9-25(20-24)34(47)41-14-15-44(2)3;1-16-7-18-4-5-19(12-20(18)8-16)23-3-2-6-40-29(23)26(11-17-9-21(34)13-22(35)10-17)41-27(44)15-43-31-28(30(42-43)32(36)37)24-14-25(24)33(31,38)39;1-19-11-21(13-26(34)12-19)14-30(37-31(39)16-24-18-36-29-9-8-25(33)17-28(24)29)32-27(7-4-10-35-32)23-6-3-5-22(15-23)20(2)38;31-23-12-19(13-24(32)16-23)11-21(30-27(7-4-10-33-30)20-5-2-1-3-6-20)14-26(36)15-22-18-34-29-9-8-25(35)17-28(22)29/h6-9,11,13,16-18,20,29H,4-5,10,12,14-15,19,21H2,1-3H3,(H,41,47)(H,42,46);2-6,9-10,12-13,24-26,32H,1,7-8,11,14-15H2,(H,41,44);3-13,15,17-18,30,36H,14,16H2,1-2H3,(H,37,39);1-10,12-13,16-18,21,34-35H,11,14-15H2/t29-;24?,25?,26-;30-;21-/m0001/s1.
What are the key properties of N-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide?
N-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide has a molecular weight of 2265.42 g/mol, XLogP of 26.21, 35 rotatable bonds, 7 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1S)-1-[3-(3-acetylphenyl)-2-pyridinyl]-2-(3-fluoro-5-methylphenyl)ethyl]-2-(5-fluoro-1H-indol-3-yl)acetamide;2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylidene-1,3-dihydroinden-5-yl)-2-pyridinyl]ethyl]acetamide;(4R)-5-(3,5-difluorophenyl)-1-(5-hydroxy-1H-indol-3-yl)-4-(3-phenyl-2-pyridinyl)pentan-2-one;N-[2-(dimethylamino)ethyl]-3-[2-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetyl]amino]ethyl]-3-pyridinyl]benzamide is sourced from PubChem (CID 158619718), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158619718 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.